BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Programmed cell death 1
1
Targeted therapy combined with immunotherapy vs trifluridine/tipiracil with bevacizumab as late-line therapy in metastatic colorectal cancer
8/5/2025 8:25:48 AM | Browse: 77 | Download: 277
2
Transarterial chemoembolization combined with lenvatinib and sintilimab vs lenvatinib alone in intermediate-advanced hepatocellular carcinoma
12/12/2024 9:30:58 AM | Browse: 116 | Download: 626
3
Landscape of transarterial chemoembolization represented interventional therapy for hepatocellular carcinoma
11/27/2024 9:42:05 AM | Browse: 87 | Download: 373
4
Programmed cell death 1 inhibitor sintilimab plus concurrent chemoradiotherapy for locally advanced pancreatic adenocarcinoma
7/16/2024 6:17:55 AM | Browse: 206 | Download: 669
5
Immune signature of small bowel adenocarcinoma and the role of tumor microenvironment
2/26/2024 1:28:46 PM | Browse: 221 | Download: 711
6
Stereotactic body radiotherapy combined with sintilimab in patients with recurrent or oligometastatic hepatocellular carcinoma: A phase II clinical trial
6/28/2023 10:03:21 AM | Browse: 292 | Download: 1343
7
Research progress regarding programmed cell death 1/programmed cell death ligand 1 inhibitors combined with targeted therapy for treating hepatocellular carcinoma
10/26/2021 8:04:00 AM | Browse: 607 | Download: 1356
8
Advances in immuno-oncology biomarkers for gastroesophageal cancer: Programmed death ligand 1, microsatellite instability, and beyond
7/5/2018 1:33:43 AM | Browse: 979 | Download: 1490
Write to the Help Desk
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345